Chromosome therapy to fight cancer

By taking advantage of a process that occurs in nature, CarryGenes has been working on a way to develop a safe and effective gene therapy that will offer novel solutions to fight cancer.

A proprietary human Synthetic Chromosome (hSynC) will act as the carrier for antitumoral factors (OncoSynC) and be introduced into the patient’s own T-cells.  Such immune cells, named Cromo-T, have the potential to maintain long-term, enhanced, tumor-killing capacity against the patient’s tumour.  

The work has paused for the moment due to lack of financial support.